Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
3(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
12
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
N/ANon-phased studies
12(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(9)

Detailed Status

Completed9
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
12
Active
3
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A12 (100.0%)

Trials by Status

recruiting325%
completed975%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
OTHER
Total Trials
12